Sanofi: Orange CEO Christel Heydemann Joins the Board
Sanofi's Board of Directors has proposed the appointment of Christel Heydemann as an independent director, which will be submitted for shareholder approval at the General Meeting on April 29, 2026. Patrick Kron will leave the Board at the end of his term.
Proposed Appointment of Christel Heydemann
The Board of Directors of Sanofi has decided to propose, at the shareholders' General Meeting scheduled for April 29, 2026, the appointment of Christel Heydemann as an independent director. Christel Heydemann is currently the CEO of Orange Group since April 2022. She previously served on the Board of Directors of Orange starting in July 2017. Her career includes leadership positions at Alcatel, where she began her career in 1999, before joining Schneider Electric in 2014, where she became CEO of Schneider Electric France in 2017, and later Director of European Operations in 2021. Christel Heydemann holds degrees from École Polytechnique and École Nationale des Ponts et Chaussées.
Changes in the Board Composition
Patrick Kron, an independent director and Chairman of the Nominations, Governance, and CSR Committee, will leave the Board of Directors at the end of his term, which concludes at the shareholders' General Meeting on April 29, 2026. The Board of Directors has also proposed the renewal of the mandates of Christophe Babule and Jean-Paul Kress. With these appointments and the arrival of Belen Garijo as CEO and director, the Board will remain composed of 16 members, including two employee representatives, with a gender parity of 57% women excluding employee directors. The composition of the specialized committees of the Board will be reviewed following the General Meeting on April 29, 2026.
